CE vs NGD

Celanese Corporation exhibits severe fundamental weakness, highlighted by a critical Piotroski F-Score of 2/9, indicating poor financial health. Despite a recent 1-year price recovery, the company is struggling with negative profit margins (-12.21%), a deeply negative ROE (-22.52%), and a high Debt/Equity ratio of 2.89. Revenue and earnings are in sharp decline, with YoY EPS growth collapsing by 88.3%. The disconnect between the bearish deterministic health scores and the 'Buy' analyst consensus suggests a speculative outlook rather than a fundamental one.

NGD presents a high-growth profile with a stable Piotroski F-Score of 4/9 and a current price ($9.08) trading very close to its growth-based intrinsic value ($9.44). While the Graham Number ($3.36) suggests a defensive undervaluation gap, the stock's massive earnings growth (275% YoY) and a highly attractive Forward P/E of 7.69 justify the current premium. Despite strong profitability and low debt/equity, short-term liquidity is a concern with a current ratio of 0.88. The overall outlook is bullish based on fundamental expansion, though technicals remain bearish in the short term.